IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock

Cytokine

Volumn 45, Issue 1, 2009, Pages 26-31

  Kobbe, Philipp ^a,b   Stoffels, Burkhard ^c   Schmidt, Joachim ^c   Tsukamoto, Takeshi ^a   Gutkin, Dmitry W ^d   Bauer, Anthony J ^c   Pape, Hans Christoph ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Department of Pathology   (United States)

Author keywords

Acute liver injury; Acute lung injury; Hemorrhagic shock; Interleukin 10; Systemic inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE;

ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ENZYME ACTIVITY; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; IMMUNOMODULATION; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; RESUSCITATION;

ACUTE LUNG INJURY; ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; SHOCK, HEMORRHAGIC;

ANIMALIA; MUS;

EID: 57749099010     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.10.004     Document Type: Article

References (35)

1. Finnerty C.C., Herndon D.N., Przkora R., Pereira C.T., Oliveira H.M., Queiroz D.M., et al. Cytokine expression profile over time in severely burned pediatric patients. Shock 26 (2006) 13-19
2. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147 (1991) 3815-3822
3. Schwacha M.G., Schneider C.P., Bland K.I., and Chaudry I.H. Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol Cell Physiol 281 (2001) C1180-C1187
4. Keel M., Ungethum U., Steckholzer U., Niederer E., Hartung T., Trentz O., et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90 (1997) 3356-3363
5. Giannoudis P.V., Smith R.M., Perry S.L., Windsor A.J., Dickson R.A., and Bellamy M.C. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 26 (2000) 1076-1081
6. Klava A., Windsor A.C., Farmery S.M., Woodhouse L.F., Reynolds J.V., Ramsden C.W., et al. Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg 132 (1997) 425-429
7. Neidhardt R., Keel M., Steckholzer U., Safret A., Ungethuem U., Trentz O., et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42 (1997) 863-870
8. Sherry R.M., Cue J.I., Goddard J.K., Parramore J.B., and DiPiro J.T. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 40 (1996) 613-616
9. Ferrer T.J., Webb J.W., Wallace B.H., Bridges C.D., Palmer H.E., Robertson R.D., et al. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS). J Surg Res 77 (1998) 157-164
10. Howard M., Muchamuel T., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177 (1993) 1205-1208
11. Rogy M.A., Auffenberg T., Espat N.J., Philip R., Remick D., Wollenberg G.K., et al. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 181 (1995) 2289-2293
12. Hauser C.J. Preclinical models of traumatic, hemorrhagic shock. Shock 24 Suppl. 1 (2005) 24-32
13. Ajuebor M.N., Das A.M., Virag L., Flower R.J., Szabo C., and Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 162 (1999) 1685-1691
14. Karakozis S., Hinds M., Cook J.W., Kim D., Provido H., and Kirkpatrick J.R. The effects of interleukin-10 in hemorrhagic shock. J Surg Res 90 (2000) 109-112
15. Welborn III M.B., Moldawer L.L., Seeger J.M., Minter R.M., and Huber T.S. Role of endogenous interleukin-10 in local and distant organ injury after visceral ischemia-reperfusion. Shock 20 (2003) 35-40
16. Yokoyama Y., Kitchens W.C., Toth B., Schwacha M.G., Rue III L.W., Bland K.I., et al. Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage. Am J Physiol Gastrointest Liver Physiol 286 (2004) G942-G946
17. Frink M., Lu A., Thobe B.M., Hsieh Y.C., Choudhry M.A., Schwacha M.G., et al. Monocyte chemoattractant protein-1 influences trauma-hemorrhage-induced distal organ damage via regulation of keratinocyte-derived chemokine production. Am J Physiol Regul Integr Comp Physiol 292 (2007) R1110-R1116
18. Kucharzik T., Lugering N., Pauels H.G., Domschke W., and Stoll R. IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol 111 (1998) 152-157
19. Olszyna D.P., Pajkrt D., Lauw F.N., van Deventer S.J., and van Der P.T. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. J Infect Dis 181 (2000) 613-620
20. Seitz M., Loetscher P., Dewald B., Towbin H., Gallati H., and Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 25 (1995) 1129-1132
21. Yano S., Yanagawa H., Nishioka Y., Mukaida N., Matsushima K., and Sone S. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol 157 (1996) 2660-2665
22. Kobbe P., Vodovotz Y., Kaczorowski D.J., Billiar T.R., and Pape H.C. The role of fracture-associated soft tissue injury in the induction of systemic inflammation and remote organ dysfunction after bilateral femur fracture. J Orthop Trauma 22 (2008) 385-390
23. Kobbe P., Vodovotz Y., Kaczorowski D.J., Mollen K.P., Billiar T.R., and Pape H.C. Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture. Shock 30 (2008) 43-47
24. Nishiyama T., Yokoyama T., and Hanaoka K. Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function. Acta Anaesthesiol Scand 43 (1999) 347-351
25. Shimada M., Winchurch R.A., Beloucif S., and Robotham J.L. Effect of anesthesia and surgery on plasma cytokine levels. J Crit Care 8 (1993) 109-116
26. Rivkind A.I., Siegel J.H., Littleton M., De Gaetano A., Mamantov T., Laghi F., et al. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock 33 (1991) 48-62
27. Malleo G., Mazzon E., Genovese T., Di Paola R., Caminiti R., Esposito E., et al. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. Cytokine 41 (2008) 136-143
28. Donnelly S.C., Strieter R.M., Reid P.T., Kunkel S.L., Burdick M.D., Armstrong I., et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 125 (1996) 191-196
29. Nagaki M., Tanaka M., Sugiyama A., Ohnishi H., and Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J Hepatol 31 (1999) 815-824
30. Santucci L., Fiorucci S., Chiorean M., Brunori P.M., Di Matteo F.M., Sidoni A., et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 111 (1996) 736-744
31. Lyons A., Goebel A., Mannick J.A., and Lederer J.A. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg 134 (1999) 1317-1323
32. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 (2003) 241-269
33. Frink M., Hsieh Y.C., Hsieh C.H., Pape H.C., Choudhry M.A., Schwacha M.G., et al. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock 28 (2007) 576-581
34. Poeze M., Ramsay G., Buurman W.A., Greve J.W., Dentener M., and Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 17 (2002) 451-458
35. Levy R.M., Prince J.M., Yang R., Mollen K.P., Liao H., Watson G.A., et al. Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am J Physiol Regul Integr Comp Physiol 291 (2006) R970-R976